{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:52:53Z","timestamp":1793213573714,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Project of the Health Commission of Heilongjiang Province of China","award":["20220202020954"],"award-info":[{"award-number":["20220202020954"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25941-1","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:45:13Z","timestamp":1764085513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["11\u03b2-HSD1 inhibitor alleviates lipid metabolism disorder by activating the AMPK signaling pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Yang","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihua","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"25941_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1514009","volume":"376","author":"SB Heymsfield","year":"2017","unstructured":"Heymsfield, S. B., Wadden, T. A. & Mechanisms Pathophysiology, and management of obesity. N Engl. J. Med. 376, 254\u2013266 (2017).","journal-title":"N Engl. J. Med."},{"key":"25941_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1530\/JOE-12-0178","volume":"214","author":"L Abrahams","year":"2012","unstructured":"Abrahams, L. et al. Biomarkers of hypothalamic-pituitary-adrenal axis activity in mice lacking 11\u03b2-HSD1 and H6PDH. J. Endocrinol. 214, 367\u2013372 (2012).","journal-title":"J. Endocrinol."},{"key":"25941_CR3","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1126\/science.1066285","volume":"294","author":"H Masuzaki","year":"2001","unstructured":"Masuzaki, H. et al. A Transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166\u20132170 (2001).","journal-title":"Science"},{"key":"25941_CR4","first-page":"2701","volume":"87","author":"O Paulmyer-Lacroix","year":"2002","unstructured":"Paulmyer-Lacroix, O., Boullu, S., Oliver, C., Alessi, M. C. & Grino, M. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J. Clin. Endocrinol. Metab. 87, 2701\u20132705 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"25941_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1152\/physiolgenomics.00067.2007","volume":"32","author":"Y Liu","year":"2008","unstructured":"Liu, Y. et al. Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis. Physiol. Genomics. 32, 343\u2013351 (2008).","journal-title":"Physiol. Genomics"},{"key":"25941_CR6","doi-asserted-by":"publisher","first-page":"108959","DOI":"10.1016\/j.biopha.2019.108959","volume":"116","author":"AP Gupta","year":"2019","unstructured":"Gupta, A. P. et al. Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL\/6 mice. Biomed. Pharmacother. 116, 108959 (2019).","journal-title":"Biomed. Pharmacother"},{"key":"25941_CR7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jsbmb.2009.01.009","volume":"113","author":"D Classen-Houben","year":"2009","unstructured":"Classen-Houben, D. et al. Selective Inhibition of 11beta-hydroxysteroid dehydrogenase 1 by 18alpha-glycyrrhetinic acid but not 18beta-glycyrrhetinic acid. J. Steroid Biochem. Mol. Biol. 113, 248\u2013252 (2009).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"25941_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1530\/JOE-13-0066","volume":"218","author":"N Tagawa","year":"2013","unstructured":"Tagawa, N., Kubota, S., Kato, I. & Kobayashi, Y. Resveratrol inhibits 11\u03b2-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes. J. Endocrinol. 218, 311\u2013320 (2013).","journal-title":"J. Endocrinol."},{"key":"25941_CR9","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.1016\/j.bmc.2012.08.056","volume":"20","author":"X Su","year":"2012","unstructured":"Su, X. et al. Adamantyl carboxamides and acetamides as potent human 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitors. Bioorg. Med. Chem. 20, 6394\u20136402 (2012).","journal-title":"Bioorg. Med. Chem."},{"key":"25941_CR10","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.2174\/0113816128303514240517054617","volume":"30","author":"S Alam","year":"2024","unstructured":"Alam, S., Lee, J. & Sahebkar, A. Curcumin in cancer prevention: insights from clinical trials and strategies to enhance bioavailability. Curr. Pharm. Des. 30, 1838\u20131851 (2024).","journal-title":"Curr. Pharm. Des."},{"key":"25941_CR11","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1021\/acs.jafc.4c11101","volume":"73","author":"KY Hsu","year":"2025","unstructured":"Hsu, K. Y., Majeed, A., Ho, C. T. & Pan, M. H. Bisdemethoxycurcumin and Curcumin alleviate inflammatory bowel disease by maintaining intestinal epithelial integrity and regulating gut microbiota in mice. J. Agric. Food Chem. 73, 3494\u20133506 (2025).","journal-title":"J. Agric. Food Chem."},{"issue":"14","key":"25941_CR12","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.3390\/ijms25147710","volume":"25","author":"S Servida","year":"2024","unstructured":"Servida, S. et al. Curcumin and Gut Microbiota: A Narrative Overview with Focus on Glycemic Control. Int J. Mol. Sci 25(14), 7710 (2024).","journal-title":"Int J. Mol. Sci"},{"key":"25941_CR13","doi-asserted-by":"publisher","first-page":"e49976","DOI":"10.1371\/journal.pone.0049976","volume":"8","author":"GX Hu","year":"2013","unstructured":"Hu, G. X. et al. Curcumin as a potent and selective inhibitor of 11\u03b2-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated rats. PLoS One. 8, e49976 (2013).","journal-title":"PLoS One"},{"key":"25941_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00394-011-0188-1","volume":"50","author":"A Shehzad","year":"2011","unstructured":"Shehzad, A., Ha, T., Subhan, F. & Lee, Y. S. New mechanisms and the anti-inflammatory role of Curcumin in obesity and obesity-related metabolic diseases. Eur. J. Nutr. 50, 151\u2013161 (2011).","journal-title":"Eur. J. Nutr."},{"key":"25941_CR15","doi-asserted-by":"publisher","first-page":"e28784","DOI":"10.1371\/journal.pone.0028784","volume":"7","author":"W Shao","year":"2012","unstructured":"Shao, W. et al. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS One. 7, e28784 (2012).","journal-title":"PLoS One"},{"key":"25941_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12986-019-0331-1","volume":"16","author":"SA Jazayeri-Tehrani","year":"2019","unstructured":"Jazayeri-Tehrani, S. A. et al. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial. Nutr. Metab. (Lond). 16, 8 (2019).","journal-title":"Nutr. Metab. (Lond)"},{"key":"25941_CR17","doi-asserted-by":"publisher","first-page":"e2559","DOI":"10.1038\/cddis.2016.455","volume":"8","author":"L Tian","year":"2017","unstructured":"Tian, L. et al. Curcumin represses mouse 3T3-L1 cell adipogenic differentiation via inhibiting miR-17-5p and stimulating the Wnt signalling pathway effector Tcf7l2. Cell. Death Dis. 8, e2559 (2017).","journal-title":"Cell. Death Dis."},{"issue":"10","key":"25941_CR18","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.3390\/nu11102307","volume":"11","author":"LY Wu","year":"2019","unstructured":"Wu, L. Y. et al. Curcumin attenuates adipogenesis by inducing preadipocyte apoptosis and inhibiting adipocyte differentiation. Nutrients 11(10), 2307 (2019).","journal-title":"Nutrients"},{"key":"25941_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jchromb.2007.03.010","volume":"853","author":"KY Yang","year":"2007","unstructured":"Yang, K. Y., Lin, L. C., Tseng, T. Y., Wang, S. C. & Tsai, T. H. Oral bioavailability of Curcumin in rat and the herbal analysis from curcuma longa by LC-MS\/MS. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 853, 183\u2013189 (2007).","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"issue":"1","key":"25941_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/nu13010206","volume":"13","author":"U Shabbir","year":"2021","unstructured":"Shabbir, U. et al. Curcumin, Quercetin, Catechins and Metabolic Diseases: The Role of Gut Microbiota. Nutrients 13(1), 206 (2021).","journal-title":"Nutrients"},{"key":"25941_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejmech.2014.03.012","volume":"77","author":"X Yuan","year":"2014","unstructured":"Yuan, X. et al. Synthesis of novel Curcumin analogues for Inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1 with anti-diabetic properties. Eur. J. Med. Chem. 77, 223\u2013230 (2014).","journal-title":"Eur. J. Med. Chem."},{"key":"25941_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejphar.2016.05.034","volume":"788","author":"X Yuan","year":"2016","unstructured":"Yuan, X. et al. The 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor protects against the insulin resistance and hepatic steatosis in db\/db mice. Eur. J. Pharmacol. 788, 140\u2013151 (2016).","journal-title":"Eur. J. Pharmacol."},{"key":"25941_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000491397","volume":"102","author":"H Liu","year":"2018","unstructured":"Liu, H. et al. 11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibitor development by lentiviral screening based on computational modeling. Pharmacology 102, 169\u2013179 (2018).","journal-title":"Pharmacology"},{"key":"25941_CR24","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1091\/mbc.e08-04-0420","volume":"19","author":"C Pantoja","year":"2008","unstructured":"Pantoja, C., Huff, J. T. & Yamamoto, K. R. Glucocorticoid signaling defines a novel commitment state during adipogenesis in vitro. Mol. Biol. Cell. 19, 4032\u20134041 (2008).","journal-title":"Mol. Biol. Cell."},{"key":"25941_CR25","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1172\/JCI114345","volume":"84","author":"H Hauner","year":"1989","unstructured":"Hauner, H. et al. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J. Clin. Invest. 84, 1663\u20131670 (1989).","journal-title":"J. Clin. Invest."},{"key":"25941_CR26","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1038\/s41467-024-52965-4","volume":"15","author":"C Zhong","year":"2024","unstructured":"Zhong, C. et al. Targeting osteoblastic 11\u03b2-HSD1 to combat high-fat diet-induced bone loss and obesity. Nat. Commun. 15, 8588 (2024).","journal-title":"Nat. Commun."},{"key":"25941_CR27","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1210\/endo-128-4-1741","volume":"128","author":"V Lakshmi","year":"1991","unstructured":"Lakshmi, V., Sakai, R. R., McEwen, B. S. & Monder, C. Regional distribution of 11 beta-hydroxysteroid dehydrogenase in rat brain. Endocrinology 128, 1741\u20131748 (1991).","journal-title":"Endocrinology"},{"key":"25941_CR28","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1210\/endo-127-3-1450","volume":"127","author":"MP Moisan","year":"1990","unstructured":"Moisan, M. P., Seckl, J. R. & Edwards, C. R. 11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex. Endocrinology 127, 1450\u20131455 (1990).","journal-title":"Endocrinology"},{"key":"25941_CR29","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1210\/endo.140.7.6868","volume":"140","author":"IJ Bujalska","year":"1999","unstructured":"Bujalska, I. J., Kumar, S., Hewison, M. & Stewart, P. M. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology 140, 3188\u20133196 (1999).","journal-title":"Endocrinology"},{"key":"25941_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1210\/clinem\/dgaa766","volume":"106","author":"RS Hardy","year":"2021","unstructured":"Hardy, R. S. et al. 11\u03b2HSD1 Inhibition with AZD4017 improves lipid profiles and lean muscle mass in idiopathic intracranial hypertension. J. Clin. Endocrinol. Metab. 106, 174\u2013187 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"25941_CR31","doi-asserted-by":"publisher","first-page":"19458","DOI":"10.1074\/jbc.M115.641332","volume":"290","author":"L Wang","year":"2015","unstructured":"Wang, L. & Di, L. J. Wnt\/\u03b2-Catenin mediates AICAR effect to increase GATA3 expression and inhibit adipogenesis. J. Biol. Chem. 290, 19458\u201319468 (2015).","journal-title":"J. Biol. Chem."},{"key":"25941_CR32","doi-asserted-by":"publisher","first-page":"10021","DOI":"10.1038\/s41598-018-27607-7","volume":"8","author":"A Dihingia","year":"2018","unstructured":"Dihingia, A., Bordoloi, J., Dutta, P., Kalita, J. & Manna, P. Hexane-Isopropanolic extract of Tungrymbai, a North-East Indian fermented soybean food prevents hepatic steatosis via regulating AMPK-mediated SREBP\/FAS\/ACC\/HMGCR and PPAR\u03b1\/CPT1A\/UCP2 pathways. Sci. Rep. 8, 10021 (2018).","journal-title":"Sci. Rep."},{"issue":"11","key":"25941_CR33","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.3390\/ijms19113534","volume":"19","author":"Y Yan","year":"2018","unstructured":"Yan, Y., Zhou, X. E., Xu, H. E. & Melcher, K. Structure and Physiological Regulation of AMPK. Int J. Mol. Sci 19(11), 3534 (2018).","journal-title":"Int J. Mol. Sci"},{"issue":"6","key":"25941_CR34","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3390\/nu13061740","volume":"13","author":"Y Pang","year":"2021","unstructured":"Pang, Y. et al. High Fat Activates O-GlcNAcylation and Affects AMPK\/ACC Pathway to Regulate Lipid Metabolism. Nutrients 13(6), 1740 (2021).","journal-title":"Nutrients"},{"key":"25941_CR35","first-page":"474","volume":"21","author":"Z Lin","year":"2013","unstructured":"Lin, Z., Zhang, B. & Liu, X. Advances of researches on AMPK-ACC signaling pathway in metabolic diseases. Chin. J. Diabetes. 21, 474\u2013477 (2013).","journal-title":"Chin. J. Diabetes"},{"key":"25941_CR36","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/cbin.10915","volume":"42","author":"R Ke","year":"2018","unstructured":"Ke, R., Xu, Q., Li, C., Luo, L. & Huang, D. Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism. Cell. Biol. Int. 42, 384\u2013392 (2018).","journal-title":"Cell. Biol. Int."},{"issue":"1","key":"25941_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/ijms17010124","volume":"17","author":"D Moseti","year":"2016","unstructured":"Moseti, D., Regassa, A. & Kim, W. K. Molecular Regulation of Adipogenesis and Potential Anti-Adipogenic Bioactive Molecules. Int J. Mol. Sci 17(1), 124 (2016).","journal-title":"Int J. Mol. Sci"},{"key":"25941_CR38","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1002\/jor.25627","volume":"41","author":"JC Parson","year":"2023","unstructured":"Parson, J. C. et al. Development and expansion of intramuscular adipose tissue is not dependent on UCP-1-lineage cells in mice. J. Orthop. Res. 41, 2599\u20132609 (2023).","journal-title":"J. Orthop. Res."},{"key":"25941_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1507\/endocrj.EJ21-0441","volume":"69","author":"B Ma","year":"2022","unstructured":"Ma, B. et al. Rutin promotes white adipose tissue Browning and brown adipose tissue activation partially through the calmodulin-dependent protein kinase kinase \u03b2\/AMP-activated protein kinase pathway. Endocr. J. 69, 385\u2013397 (2022).","journal-title":"Endocr. J."},{"key":"25941_CR40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.cmet.2012.01.019","volume":"15","author":"H Ohno","year":"2012","unstructured":"Ohno, H., Shinoda, K., Spiegelman, B. M. & Kajimura, S. PPAR\u03b3 agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell. Metab. 15, 395\u2013404 (2012).","journal-title":"Cell. Metab."},{"key":"25941_CR41","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1194\/jlr.R200009-JLR200","volume":"43","author":"FB Kraemer","year":"2002","unstructured":"Kraemer, F. B. & Shen, W. J. Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis. J. Lipid Res. 43, 1585\u20131594 (2002).","journal-title":"J. Lipid Res."},{"key":"25941_CR42","doi-asserted-by":"publisher","first-page":"e2401311","DOI":"10.1002\/advs.202401311","volume":"11","author":"S Ouyang","year":"2024","unstructured":"Ouyang, S. et al. Glycerol kinase drives hepatic de Novo lipogenesis and triglyceride synthesis in nonalcoholic fatty liver by activating SREBP-1c Transcription, upregulating DGAT1\/2 Expression, and promoting glycerol metabolism. Adv. Sci. (Weinh). 11, e2401311 (2024).","journal-title":"Adv. Sci. (Weinh)"},{"key":"25941_CR43","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3389\/fnins.2017.00558","volume":"11","author":"Z Liu","year":"2017","unstructured":"Liu, Z. et al. Curcumin activates AMPK pathway and regulates lipid metabolism in rats following prolonged clozapine exposure. Front. Neurosci. 11, 558 (2017).","journal-title":"Front. Neurosci."},{"key":"25941_CR44","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.3390\/molecules18032726","volume":"18","author":"CC Shih","year":"2013","unstructured":"Shih, C. C., Ciou, J. L., Lin, C. H., Wu, J. B. & Ho, H. Y. Cell suspension culture of eriobotrya Japonica regulates the diabetic and hyperlipidemic signs of high-fat-fed mice. Molecules 18, 2726\u20132753 (2013).","journal-title":"Molecules"},{"key":"25941_CR45","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.febslet.2013.12.014","volume":"588","author":"B Legeza","year":"2014","unstructured":"Legeza, B., Bal\u00e1zs, Z. & Odermatt, A. Fructose promotes the differentiation of 3T3-L1 adipocytes and accelerates lipid metabolism. FEBS Lett. 588, 490\u2013496 (2014).","journal-title":"FEBS Lett."},{"key":"25941_CR46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.biocel.2016.08.044","volume":"81","author":"A Bettaieb","year":"2016","unstructured":"Bettaieb, A. et al. Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice. Int. J. Biochem. Cell. Biol. 81, 383\u2013392 (2016).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"25941_CR47","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1038\/s41598-017-04308-1","volume":"7","author":"LN Masi","year":"2017","unstructured":"Masi, L. N. et al. Combination of a high-fat diet with sweetened condensed milk exacerbates inflammation and insulin resistance induced by each separately in mice. Sci. Rep. 7, 3937 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25941-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25941-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25941-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T17:03:39Z","timestamp":1764090219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25941-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25941"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25941-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41968"}}